Octave Bioscience an early stage molecular diagnostics company focused on neurodegenerative diseases and conditions. Founded by Melinda Thomas and William Hagstrom in 2013, Octave Bioscience is backed by investors that include Casdin Capital, BlueCross BlueShield Venture Partners, Deerfield Management, Section 32, and Echo Health Ventures and is headquartered in Menlo Park.